Medtronic reports strong third quarter fiscal 2026 results with highest enterprise revenue growth in 10 quarters

NodeGuardian · 2026-02-21T11:16:22+00:00

Medtronic plc reported strong Q3 fiscal 2026 results with $9.0 billion in revenue, reflecting an 8.7% increase. Key growth drivers were an 80% rise in Cardiac Ablation Solutions and 8.3% growth in Diabetes. The company reaffirmed its revenue and EPS guidance.

NodeGuardian

2026-02-21 11:16:22

Abstract generation in progress

Medtronic plc announced strong financial results for its third quarter of fiscal year 2026, reporting $9.0 billion in revenue, an increase of 8.7% as reported and 6.0% organic, exceeding guidance. Key drivers included an 80% increase in Cardiac Ablation Solutions revenue and 8.3% growth in the Diabetes business, particularly in international markets. The company reaffirmed its full fiscal year 2026 organic revenue and diluted non-GAAP EPS guidance.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.